Literature DB >> 21299337

Preferential and bidirectional labeling of the rubrospinal tract with adenovirus-GFP for monitoring normal and injured axons.

Xiaofei Wang1, George M Smith, Xiao-Ming Xu.   

Abstract

The rodent rubrospinal tract (RST) has been studied extensively to investigate regeneration and remodeling of central nervous system (CNS) axons. Currently no retrograde tracers can specifically label rubrospinal axons and neurons (RSNs). The RST can be anterogradely labeled by injecting tracers into the red nucleus (RN), but accurately locating the RN is a technical challenge. Here we developed a recombinant adenovirus carrying a green fluorescent protein reporter gene (Adv-GFP) which can preferentially, intensely, and bi-directionally label the RST. When Adv-GFP was injected into the second lumbar spinal cord, the GFP was specifically transported throughout the entire RST, with peak labeling seen at 2 weeks post-injection. When Adv-GFP was injected directly into the RN, GFP was anterogradely transported throughout the RST. Following spinal cord injury (SCI), injection of Adv-GFP resulted in visualization of GFP in transected, spared, or sprouted RST axons bi-directionally. Thus Adv-GFP could be used as a novel tool for monitoring and evaluating strategies designed to maximize RST axonal regeneration and remodeling following SCI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21299337      PMCID: PMC3070148          DOI: 10.1089/neu.2010.1566

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  54 in total

1.  Integrin subunit gene expression is regionally differentiated in adult brain.

Authors:  J K Pinkstaff; J Detterich; G Lynch; C Gall
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade.

Authors:  M I Romero; G M Smith
Journal:  Gene Ther       Date:  1998-12       Impact factor: 5.250

3.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Application of recombinant adenovirus for in vivo gene delivery to spinal cord.

Authors:  Y Liu; B T Himes; J Moul; W Huang; S Y Chow; A Tessler; I Fischer
Journal:  Brain Res       Date:  1997-09-12       Impact factor: 3.252

5.  Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function.

Authors:  Y Liu; D Kim; B T Himes; S Y Chow; T Schallert; M Murray; A Tessler; I Fischer
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

6.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.

Authors:  G Haase; P Kennel; B Pettmann; E Vigne; S Akli; F Revah; H Schmalbruch; A Kahn
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

8.  BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration.

Authors:  N R Kobayashi; D P Fan; K M Giehl; A M Bedard; S J Wiegand; W Tetzlaff
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

9.  Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat.

Authors:  Qilin Cao; Yi Ping Zhang; Christopher Iannotti; William H DeVries; Xiao-Ming Xu; Christopher B Shields; Scott R Whittemore
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

Review 10.  Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function.

Authors:  A G Teschemacher; S Wang; T Lonergan; H Duale; H Waki; J F R Paton; S Kasparov
Journal:  Exp Physiol       Date:  2004-11-12       Impact factor: 2.969

View more
  5 in total

1.  The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration.

Authors:  Ryan R Williams; Damien D Pearse; Patrick A Tresco; Mary Bartlett Bunge
Journal:  J Gene Med       Date:  2012-01       Impact factor: 4.565

2.  Retrogradely Transportable Lentivirus Tracers for Mapping Spinal Cord Locomotor Circuits.

Authors:  Imran S Sheikh; Kathleen M Keefe; Noelle A Sterling; Ian P Junker; Chidubem I Eneanya; Yingpeng Liu; Xiao-Qing Tang; George M Smith
Journal:  Front Neural Circuits       Date:  2018-07-25       Impact factor: 3.492

3.  Neurod4 converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injury.

Authors:  Toshiki Fukuoka; Akira Kato; Masaki Hirano; Fumiharu Ohka; Kosuke Aoki; Takayuki Awaya; Alimu Adilijiang; Maeda Sachi; Kuniaki Tanahashi; Junya Yamaguchi; Kazuya Motomura; Hiroyuki Shimizu; Yoshitaka Nagashima; Ryo Ando; Toshihiko Wakabayashi; Dasfne Lee-Liu; Juan Larrain; Yusuke Nishimura; Atsushi Natsume
Journal:  iScience       Date:  2021-01-20

Review 4.  Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.

Authors:  Anastasiia O Sosnovtseva; Olga V Stepanova; Aleksei A Stepanenko; Anastasia D Voronova; Andrey V Chadin; Marat P Valikhov; Vladimir P Chekhonin
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

5.  Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration.

Authors:  Yingpeng Liu; Kathy Keefe; Xiaoqing Tang; Shen Lin; George M Smith
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.